BGP Stent as Bridging Stent in FEVAR

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.

Also called NCT03987035

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 103 participants (enrolled count) (from the registry)
Sponsor
Marc Bosiers, MD (from the registry)
Registry
  • NCT NCT03987035
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03987035. Allocation not applicable; no masking; primary purpose treatment. Start 2021-03-18 (actual); primary completion 2022-07-19 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BGP Stent as Bridging Stent in FEVAR
Condition
Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture
Condition
Abdominal Aortic Aneurysm, Without Mention of Rupture
Intervention (Device)
BeGraft Peripheral (BGP) Stent Graft System as bridging stent
Lead sponsor
Marc Bosiers, MD (class: other)

Record details

Record id
cardio:ct-nct03987035
Content hash
1c936fabfc9fd19702257cf286413c1971371022803266e577b60415c0669fb1